3 Functional Analysis of Novel Antimicrobial Peptide, AG (Angiogenic Peptide)-30, with Angiongenic Property, toward Clinical Application(The 71st Annual Scientific Meeting of the Japanese Circulation Society)
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本循環器学会の論文
- 2007-03-01
著者
-
tabata yasuhiko
Department of Biomaterials, Institute for Frontier Medical Science, Kyoto university
-
OGIHARA Toshio
Department of Geriatric Medicine, Osaka University Graduate School of Medicine
-
NAKAGAMI Hironori
Division of Gene Therapy Science, Osaka University Graduate School of Medicine
-
Nakagami Hironori
Division Of Gene Therapy Science Osaka University Graduate School Of Medicine
-
Takami Yoichi
Department Of Geriatric Medicine And Nephrology Osaka University Graduate School Of Medicine
-
KANEDA Yasufumi
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University
-
Tabara Yasuharu
国立循環器病センター研究所 疫学部
-
Niki Hisae
国立がんセンター中央病院 消化器内科
-
Morishita Ryuichi
Division Of Gene Therapy Science Osaka University Graduate School Of Medicine
-
Nakahama Hajime
Division Of Hypertension And Nephrology National Cardiovascular Center
-
Katanosaka Yuki
国立循環器病センター
-
Nakagami Hironori
Division Of Clinical Gene Therapy Osaka University Graduate School Of Medicine
-
Tatara Yuji
大阪大学 老年･腎臓内科学
-
Nonogi Hiroshi
Saitama Medical University
-
Ogihara Toshio
Department Of Geriatic Medicine
-
Kaneda Yasufumi
Division Of Clinical Gene Therapy Osaka University Graduate School Of Medicine
-
Tomono Kazunori
Division Of Infection Control And Prevention Osaka Universaity Graduate School Of Medicine
-
NISHIKAWA Tomoyuki
Division of Gene Therapy Science, Department of Oncology, Biomedical Research Center, Osaka Universi
-
Tabata Yasuhiko
Department Of Biomaterials Field Of Tissue Engineering Institute For Frontier Medical Sciences Kyoto
-
Tomino Yasuhiko
Department Of Medicine Juntendo University School Of Medicine
-
TAKADA YASUHARU
Saijo Central Hospital
-
Tatsu Yoshihiro
National Institute of Advanced Industrial Science and Technology
-
Morishita Ryuichi
Division Of Clinical Gene Therapy
-
Taniyama Yoshiaki
Department Of Clinical Gene Therapy
-
Takemura Yukihiro
Department Of Geriatric Medicine And Nephrology Osaka University Graduate School Of Medicine
-
Nonogi Hiroshi
Department Of Cardiology Medical School Osaka University
-
Nonogi Hiroshi
Division Of Cardiac Care Unit Department Of Cardiovascular Medicine National Cerebral And Cardiovasc
-
Nishikawa Tomoyuki
Division Of Gene Therapy Science Osaka University
-
Morishita Ryuichi
Department Cf Clinical Gene Therapy Graduate School Of Medicine Osaka University
-
Morishita Ryuichi
Division Of Clinical Gene Therapy Graduate School Of Medicine Osaka University
-
Hayashi Norihiro
Department Of Clinical Pharmacology And Pharmacogenomics Graduate School Of Pharmaceutical Sciences Osaka University
関連論文
- Association of gene polymorphism of the fat-mass and obesity-associated gene with insulin resistance in Japanese
- PJ-335 Cell Therapy Improves Cardiac Dyssynchrony and Reduces the Transmural Extent of the Ischemic Regions in Chronic Myocardial Infarction(PJ057,Translational Science (Cardiac) (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japa
- 5 Cardiac Regenerative Hybrid-therapy Integrated via Human Autologous Cardiac Stem Cell and Biodegradable bFGF-incorporating Gelatin Hydrogel(Therapeutic Strategy for Severe Heart Failure-From LVAD to Heart Transplantation-,Symposium 11 (SY-11) (H),The 73
- A Promoter Polymorphism of Lamin A/C Gene is an Independent Genetic Predisposition to Arterial Stiffness in a Japanese General Population (The Tanno and Sobetsu Study)
- Association of SLC6A9 Gene Variants with Human Essential Hypertension
- Contribution of Adiponectin Gene Mutation to Coronary Artery Disease
- OE-070 Post-Infarct Treatment with an Erythropoietin-Gelatin Hydrogel Patchlmproves Cardiac Function by Activating Prosurvival Signaling and exerting Antifibrotic and Angiogenic Effects(Genetics/Genetically engineered models/Gene therapy(M),Oral Presentat
- OJ-254 Erythropoietin Drug Delivery System protects the heart against myocardial infarction through activation of Akt and angiogenesis(Growth factor/Cytokine-2(H/M), The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-335 Cell Therapy Improves Cardiac Dyssynchrony and Reduces the Transmural Extent of the Ischemic Regions in Chronic Myocardial Infarction(PJ057,Translational Science (Cardiac) (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japa
- 5 Cardiac Regenerative Hybrid-therapy Integrated via Human Autologous Cardiac Stem Cell and Biodegradable bFGF-incorporating Gelatin Hydrogel(Therapeutic Strategy for Severe Heart Failure-From LVAD to Heart Transplantation-,Symposium 11 (SY-11) (H),The 73
- OE-237 Dose-dependent Functional Recovery of Human Cardiac Stem Cell Transplantation Combined with Control-Delivery of Angiogenic Growth Factor in Chronic Myocardial Infarction(Regeneration(angiogenesis/myocardial regeneration)(01)(M),Oral Presentation(En
- 3 Human cardiac stem cell biotherapy Integrated with bFGF controlled-release : Two randomized, dose-ranging, controlled preclinical trial(Symposium 12 (SY-12) (M) Clinical Experiences of Regenerative Medicine in Cardiovascular Diseases,Special Program,The
- OE-071 A Genom-Wide Association Study of SNPs in the risk of Atherosclerosis Obliterans(Heart failure, clinical(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- MHC-LINKED SUSCEPTIBILITY TO TYPE 1 DIABETES IN THE NOD MOUSE : FURTHER LOCALIZATION OF Idd16 BY SUBCONGENIC ANALYSIS
- N/P Ratio Significantly Influences the Transfection Efficiency and Cytotoxicity of a Polyethylenimine/Chitosan/DNA Complex(Miscellaneous)
- Combination of Poly(ethylenimine) and Chitosan Induces High Gene Transfection Efficiency and Low Cytotoxicity(MISCELLANEOUS)
- PJ-335 Cell Therapy Improves Cardiac Dyssynchrony and Reduces the Transmural Extent of the Ischemic Regions in Chronic Myocardial Infarction(PJ057,Translational Science (Cardiac) (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japa
- 5 Cardiac Regenerative Hybrid-therapy Integrated via Human Autologous Cardiac Stem Cell and Biodegradable bFGF-incorporating Gelatin Hydrogel(Therapeutic Strategy for Severe Heart Failure-From LVAD to Heart Transplantation-,Symposium 11 (SY-11) (H),The 73
- OE-237 Dose-dependent Functional Recovery of Human Cardiac Stem Cell Transplantation Combined with Control-Delivery of Angiogenic Growth Factor in Chronic Myocardial Infarction(Regeneration(angiogenesis/myocardial regeneration)(01)(M),Oral Presentation(En
- 3 Human cardiac stem cell biotherapy Integrated with bFGF controlled-release : Two randomized, dose-ranging, controlled preclinical trial(Symposium 12 (SY-12) (M) Clinical Experiences of Regenerative Medicine in Cardiovascular Diseases,Special Program,The
- PJ-642 A Polymorphism in Promoter Region of CYP4A11 Gene is Associated with a New Onset of Hypertension : the Tanno-Sobetsu Study(Hypertension, basic-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Effects of Angiotensin II Type 1 Receptor Gene Polymorphisms on Insulin Resistance in a Japanese General Population : The Tanno-Sobetsu Study
- Comparison of Arterial Functional Evaluations as a Predictor of Cardiovascular Events in Hypertensive Patients : The Non-Invasive Atherosclerotic Evaluation in Hypertension (NOAH) Study
- Renal Protective Effect in Hypertensive Patients : The High Doses of Angiotensin II Receptor Blocker (HARB) Study
- Renal-Protective Effect of T- and L-Type Calcium Channel Blockers in Hypertensive Patients : An Amlodipine-to-Benidipine Changeover (ABC) Study
- Alveolar bone tissue engineering using composite scaffolds for drug delivery
- PE-187 Sustained Release of Granulocyte Colony-Stimulating Factor Using Biodegradable Gelatin Hydrogel Improves Limb Ischemia(PE032,Peripheral Circulation/Vascular Disease (Pathophysiology, Basic) (H),Poster Session (English),The 73rd Annual Scientific Me
- PE-117 Sustained Release of Erythropoietin Using Biodegradable Gelatin Hydrogel Persistently Improves Lower Leg Ischemia without Evoking Polycytemia(Peripheral circulation/Vascular disease(03)(H),Poster Session(English),The 72nd Annual Scientific Meeting
- OE-070 Post-Infarct Treatment with an Erythropoietin-Gelatin Hydrogel Patchlmproves Cardiac Function by Activating Prosurvival Signaling and exerting Antifibrotic and Angiogenic Effects(Genetics/Genetically engineered models/Gene therapy(M),Oral Presentat
- PJ-335 Cell Therapy Improves Cardiac Dyssynchrony and Reduces the Transmural Extent of the Ischemic Regions in Chronic Myocardial Infarction(PJ057,Translational Science (Cardiac) (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japa
- 5 Cardiac Regenerative Hybrid-therapy Integrated via Human Autologous Cardiac Stem Cell and Biodegradable bFGF-incorporating Gelatin Hydrogel(Therapeutic Strategy for Severe Heart Failure-From LVAD to Heart Transplantation-,Symposium 11 (SY-11) (H),The 73
- OE-237 Dose-dependent Functional Recovery of Human Cardiac Stem Cell Transplantation Combined with Control-Delivery of Angiogenic Growth Factor in Chronic Myocardial Infarction(Regeneration(angiogenesis/myocardial regeneration)(01)(M),Oral Presentation(En
- 3 Human cardiac stem cell biotherapy Integrated with bFGF controlled-release : Two randomized, dose-ranging, controlled preclinical trial(Symposium 12 (SY-12) (M) Clinical Experiences of Regenerative Medicine in Cardiovascular Diseases,Special Program,The
- Preparation of injectable 3D-formed β-tricalcium phosphate bead/alginate composite for bone tissue engineering
- OJ-314 Drug Delivery System Using Erythropoietin Gelatin Hydrogel Sheet Decreases Myocardial Infarct Size and Improves Left Ventricular Function and Remodeling(Growth factor/Cytokine-1 (H) OJ53,Oral Presentation (Japanese),The 70th Anniversary Annual Scie
- Gene-environmental interaction regarding alcohol-metabolizing enzymes in the Japanese general population
- PJ-618 Evaluation of 14 Genes Involved in Reverse Cholesterol Transport in the Japanese General Population(Genetics/Genetically engineered models/Gene therapy-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- High blood pressure worsens age-related increases in arterial stiffness evaluated by pulse wave velocity in subjects with lifestyle-related diseases
- Fas Ligand mRNA Levels of Circulating Leukocytes Reflect Endothelial Dysfunction in Hyperlipidemic but Not in Non-Hyperlipidemic Patients
- PJ-032 Fas Ligand Expression Levels in Mononuclear Cells May Indicate the Degree of Improvement of Endothelial Function by Statin(Endothelium-5 (H) PJ6,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation So
- Fas Ligand mRNA Levels of Peripheral Blood Mononuclear Cells may be a Novel Clinical Marker in Patients with Hyperlipidemia (Atherosclerosis, Clinical 10 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Green Coffee Bean Extract Improves Human Vasoreactivity
- β3-Adrenergic Receptor Trp64arg Polymorphism Is Related with Endothelial Dysfunction via Increased Oxidized Stress in Proportion to Increasing Sympathetic Nervous Activity
- Intercellular Adhesion Molecule-1 G241R Polymorphism Influences Increasing Arterial Stiffness
- Single Nucleotide Polymorphisms of Ligand-Receptor System of Monocyte Chemoattractant Protein-1 Influence Different Arterial Dysfunctions with Serum Interleukin-15 Elevation
- Hypertension Attenuates the Efficacy of Hypoglycemic Therapy for Preserving Coronary Flow Reserve in Patients with Type 2 Diabetes
- Plasma levels of inflammatory related substances are correlated with severity of aortic stiffness and endothelial dysfunction in hypertensive patients
- Plasma level of 8-hydroxydeoxyguanosine, a marker of oxidative stress, was correlated to endothelial dysfunction in hypertensive patients
- Serum hepatocyte growth factor concentration is a specific marker of endothelial dysfunction in humans
- Low-Dose Doxazosin Imoroved Aortic Stiffness and Endothelial Dysfunction as Measured by Noninvasive Evaluation
- Controlled Release of Matrix Metalloproteinase-1 Plasmid DNA Prevents Left Ventricular Remodeling in Chronic Myocardial Infarction of Rats
- OE-018 E-NTPDase Gene Eluting Stent Prevents Subacute Thrombosis in the Balloon-injured Arteries of Rabbit(Acute coronary syndrome, basic/clinical(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Fabrication of three-dimensional cell scaffolds with spatial gradients of biomolecules
- PE-084 In Vitro Myogenic Differentiation of Bone Marrow Stem Cells by Condition Medium(Tissue Engineering (H) : PE15)(Poster Session (English))
- Recent advances in tissue engineering for regeneration of oral tissues
- Enhanced Osteoinduction by Biodegradable Gelatin-β-tricalcium Phosphate Sponge Capable for Bone Morphogenetic Protein Release(International Symposium of Maxillofacial and Oral Regenerative Biology in Okayama 2005)
- Enhanced osteoinduction by biodegradable gelatin-tricalcium phosphate sponge incorporating bone morphogenetic protein(13^ Annual Meeting of the Society for Hard Tissue Regenerative Biology)
- Bioartificial Pancreas Transplantation at Prevascularized Intermuscular Space : Effect of Angiogenesis Induction on Islet Survival
- Letters to the Editor
- Letters to the Editor
- Effect of Aminated Gelatin on the Nasal Absorption of Insulin in Rats(Biopharmacy)
- Sustained Release of Prostaglandin E_1 Potentiates the Impaired Therapeutic Angiogenesis by Basic Fibroblast Growth Factor in Diabetic Murine Hindlimb Ischemia
- New Therapeutic Approach for Impaired Arteriogenesis in Diabetic Mouse Hindlimb Ischemia
- A Novel Approach to Therapeutic Angiogenesis for Patients With Critical Limb Ischemia by Sustained Release of Basic Fibroblast Growth Factor Using Biodegradable Gelatin Hydrogel : An Initial Report of the Phase I-IIa Study
- 4 Control-release of MMP-1 Plasmid DNA Improved Contractility and Altered Na/Ca Exchange of Cardiomyocytes Isolated from Rat Chronic Myocardial Infarction Heart(The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- 4 Towards New Era for Regenerative Medicine in Cardiovascular Area(Regeneration Therapy Using Tissue Engineering, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Combined Treatment With Sustained-Release Basic Fibroblast Growth Factor and Heparin Enhances Neovascularization in Hypercholesterolemic Mouse Hindlimb Ischemia
- Sustained-Release Erythropoietin Ameliorates Cardiac Function in Infarcted Rat-Heart Without Inducing Polycythemia
- PJ-118 Combined Treatment of Sustained-release Basic Fibroblast Growth Factor and Heparin Enhances Angiogenesis in Hypercholesterolemic Mouse Hindlimb Ischemia(Peripheral circulation-8 (H) PJ20,Poster Session (Japanese),The 70th Anniversary Annual Scienti
- Therapeutic angiogenesis by the controlled release of basic fibroblast growth factor for ischemic limb and heart injury : toward safety and minimal invasiveness
- Dual Release of Basic Fibroblast Growth Factor and Hepatocyte Growth Factor from Biodegradable Collagen Microsphere Synergistically Enhances Therapeutic Angiogenesis and Promotes Vascular Maturation in Critical Limb Ischemia
- Targeting of Plasmid DNA to Renal Interstitial Fibroblasts by Cationized Gelatin(Biopharmacy)
- Cranial Bone Regeneration by Controlled Release of Platelet Growth Factors from Biodegradable Hydrogel(International Symposium of Maxillofacial and Oral Regenerative Biology in Okayama 2005)
- Augmented Bone Regeneration Activity of Platelet-Rich Plasma by Biodegradable Hydrogel(13^ Annual Meeting of the Society for Hard Tissue Regenerative Biology)
- 12.Experimental study on a newly modified preparation of prefabricated vascularized bone graft for bone reconstruction(12th Annual Meeting of the Society of Hard Tissue Biology)
- OJ-046 Aspirin Acts as a Protective Agent against Myocardial Cell Apoptosis via the Activation of Extracellular Signal-Regulated Kinase and P300(Antithrombofic Ttherapy (H) : OJ6)(Oral Presentation (Japanese))
- Phagocytes Transfected with Biodegradable Gelatin Allow Tissue-Targeted and Less Invasive Gene Therapy
- Regenerative medical therapy from the viewpoint of biomaterials
- 3 Functional Analysis of Novel Antimicrobial Peptide, AG (Angiogenic Peptide)-30, with Angiongenic Property, toward Clinical Application(The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Properties of osteoinduction and BMP-2 release in functionally graded HAp(15thAnnual Meeting of the Society for Hard Tissue Regenerative Biology,Session 2)
- A novel bFGF-GH injection therapy for two patients with severe ischemic limb pain
- Collagen-poly glycolic acid hybrid matrix with basic fibroblast growth factor accelerated angiogenesis and granulation tissue formation in diabetic mice
- OE-100 Protein Therapy Using Control-Released b-FGF in Patients with Ischemic Limbs : a Possible Alternative to Bone Marrow Mononuclear Cell Implantation(Regeneration (angiogenesis/myocardial regeneration)-1, The 71st Annual Scientific Meeting of the Japa
- PJ-002 Effect of Combination Therapy with Sustained-Release bFGF and G-CSF on Angiogenesis and Cardiac Function in Myocardial Ischemia(Acute myocardial infarction, basic(02)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese
- Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma
- S2-5 Inhibition of Heat shock protein 47 expression as a therapy for peritoneal sclerosis(THE 46TH ANNUAL MEETING OF THE JAPAN SOCIETY OF HISTOCHEMISTRY AND CYTOCHEMISTRY)
- Influence of basic fibroblast growth factor in the solution and adsorbed form on the proliferation and differentiation of cells
- Experimental tissue regeneration by DDS technology of bio-signaling molecules
- Fabrication of Non-woven Mats of Gelatin/Poly(L-lactic acid) Composites by Electrospinning and Their Application for Scaffold of Cell Proliferation
- Development of New Drug Delivery System for Implant Bone Augmentation Using a basic Fibroblast Growth Factor-gelatin Hydrogel Complex
- Potential of Drug Delivery Technology in Tissue Regeneration Therapy
- 2 Cadiovascular Regeneration Therapy Based on DDS Technology(Latest Development of Nanotechnology Revolutionizes Treatments of Cardiovascular Diseases,Topic 3 (TP-3) (H),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PE-309 The Experiment for improving the patency of the vein graft for CABG(Cardiovascular Surgery/CABG 3 (IHD) : PE53)(Poster Session (English))
- Frontier of Tissue Engineering Indispensable for Cardiovascular Regeneration Therapy(Mashimo Memorial Lecture,The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- Mechanisms of HERS formation and development of tooth root formation technology(15thAnnual Meeting of the Society for Hard Tissue Regenerative Biology,Session 2)
- Regeneration induction therapy based on DDS technology of growth factors(15thAnnual Meeting of the Society for Hard Tissue Regenerative Biology,Session 2)
- 1 Hybrid Cell-gene Therapy for Pulmonary Hypertension Based on Phagocytosing Action of Endothelial Progenitor Cells(Plenary Session 8 (PL8) (IHD) : Toward Optimal Transplant Programs in Japan : from Cellular, Tissue and Solid Organ Aspects)(Special Progra
- Turn-on Detection of Targeted Biochemical Reactions by Triple Resonance NMR Analysis Using Isotope-labeled Probe
- Regenerative Medical Therapy for Hard Tissues Based on Tissue Engineering(International Symposium of Maxillofacial and Oral Regenerative Biology in Okayama 2005)
- Non-viral vectors for cancer therapy